This report provides a comprehensive strategic analysis of AstraZeneca, a British-Swedish pharmaceutical company. The report begins with an introduction to strategic management and sustainability, followed by a company description outlining AstraZeneca's mission, values, and business strategies, particularly its role during the COVID-19 pandemic. A stakeholder mapping identifies key groups and their influence. The core of the analysis utilizes frameworks such as PESTLE, Porter's Five Forces, SWOT analysis, and the industry life cycle to evaluate AstraZeneca's external and competitive environments. The PESTLE analysis examines political, economic, social, technological, legal, and environmental factors affecting the pharmaceutical industry and AstraZeneca. Porter's Five Forces assesses the threats of new entrants, buyer power, supplier power, substitute products, and competitive rivalry. The SWOT analysis highlights AstraZeneca's strengths, weaknesses, opportunities, and threats. The industry life cycle analysis places AstraZeneca within its current stage of development. Key findings are presented, and the report concludes with recommendations. The report emphasizes AstraZeneca's response to the COVID-19 pandemic, its vaccine development efforts, and its strategic positioning in the market. The report is a detailed analysis, providing a comprehensive understanding of AstraZeneca's strategic management and sustainability.
![[object Object]](/_next/static/media/star-bottom.7253800d.svg)
